News & Events

You are here

9
May

W. magna, 90% efficacy on mildew

Lyon, 4th Mai 2018 - AMOEBA announces today the first greenhouse test results conducted with the microorganism, Willaertia magna C2c Maky, used as a biocontrol agent for the control of mildew on grapevine.

 The results of the first greenhouse trials show very clear dose-responses of Willaertia magna C2c Maky in a formulated product. The efficacy of more than 90% of the formulated product on mildew has to be compared to the usual efficacy of biocontrol agents of around 50% observed in greenhouses. A new series of tests is scheduled in 2018 in preparation of the field trials planned in 2019. 

These first greenhouse tests, which confirm the previous in vitro trials (see our press release dated November 22, 2017), are a fundamental milestone to validate the potential use of Willaertia magna C2c Maky as an alternative to traditional chemical products. These tests were carried out by CONIDIA, an independent recognized expert in fungi and their resistance to fungicides.

This milestone will enable the Company to...

Read More
28
Jul

LOI signature on new US territory

Lyon (France), Atlanta (GA, USA), July 27th, 2017 – Amoéba announced today that it has signed a Letter of Intent (LOI) with MOMAR Inc....

10
Jul

Fabrice Plasson elected to WssTP

Fabrice Plasson, CEO of Amoéba, was elected at the new board of the WssTP’s, for the period 2017-2019. He’ll be representing College D: Suppliers...

28
Jun

Collaboration for wound care treatment

Lyon, Cleveland, June 27th, 2017 - AMOEBA announced today the development of a collaboration with VISCUS BIOLOGICS in order to carry out...

23
May

1st distribution agreement in USA

Lyon, France & Chicago, USA, May 22nd, 2017 – Amoéba announced today the signature with Earthwise Environmental of the first...

15
May

Novochem signs a distribution agreement

Lyon, Houten, May 15th 2017 – Amoéba announced today that it has signed a distribution agreement for its BIOMEBA product with...